Showing results (1621-1630 of 1,668) with videos related to

Sort By:
Pageof 167
European Journal of Cancer (Oxford, England : 1990)|November 1, 2024
Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohortDavid Tougeron, Frederic Bibeau, Benoist Chibaudel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2014
Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapyGilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut, et al.
Environmental Microbiology|September 6, 2022
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age childrenAgnes Delaunay-Moisan, Tiffany Guilleminot, Michaela Semeraro, et al.
Journal of Inherited Metabolic Disease|April 23, 2022
Influence of early identification and therapy on long-term outcomes in early-onset MTHFR deficiencyMathilde Yverneau, Stéphanie Leroux, Apolline Imbard, et al.
Nature Immunology|May 7, 2013
The transcriptional landscape of αβ T cell differentiationMichael Mingueneau, Taras Kreslavsky, Daniel Gray, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 5, 2025
Long-term bowel function following delayed coloanal anastomosis: Analysis of a multicentric cohort study (GRECCAR)Maxime K Collard, Jean-Jacques Tuech, Charles Sabbagh, et al.
Journal of Inherited Metabolic Disease|September 15, 2020
Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defectClaire-Marine Bérat, Sebastian Montealegre, Arnaud Wiedemann, et al.
Nature Communications|February 4, 2018
Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patientsJean-Louis Guéant, Céline Chéry, Abderrahim Oussalah, et al.
Pageof 167